Guidelines on Nuclear Medicine Imaging in Neuroblastoma

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2018 Jun 26

PMID 29938300

Citations 46

Authors

Zvi Bar-Sever

Lorenzo Biassoni

Barry Shulkin

Grace Kong

Michael S Hofman

Egesta Lopci

Irina Manea

Jacek Koziorowski

Rita Castellani

Ariane Boubaker

Bieke Lambert

Thomas Pfluger

Helen Nadel

Susan Sharp

Francesco Giammarile

Affiliations

Soon will be listed here.

Abstract

Nuclear medicine has a central role in the diagnosis, staging, response assessment and long-term follow-up of neuroblastoma, the most common solid extracranial tumour in children. These EANM guidelines include updated information on I-mIBG, the most common study in nuclear medicine for the evaluation of neuroblastoma, and on PET/CT imaging with F-FDG, F-DOPA and Ga-DOTA peptides. These PET/CT studies are increasingly employed in clinical practice. Indications, advantages and limitations are presented along with recommendations on study protocols, interpretation of findings and reporting results.

Citing Articles

Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research.

Sharma R, Yadav J, Bhat S, Musayev A, Myrzagulova S, Sharma D Mol Neurobiol. 2025; .

PMID: 39804528 DOI: 10.1007/s12035-024-04680-w.

Application of modified Curie and SIOPEN skeleton scoring systems in F-AlF-NOTA-octreotide PET/CT for neuroblastoma.

Li S, Sang B, Liu J, Liu Y, Xu Y, Sun X Ann Nucl Med. 2024; .

PMID: 39674843 DOI: 10.1007/s12149-024-02006-3.

Recommendations for the use of nuclear medicine imaging in patients with neuroblastoma.

Sanchez-Vano R, Balaguer J, Borrego-Dorado I, Esteban-Figueruelo A, Gamez C, Hladun R Clin Transl Oncol. 2024; .

PMID: 39508974 DOI: 10.1007/s12094-024-03755-3.

Performing [F]MFBG Long-Axial-Field-of-View PET/CT Without Sedation or General Anesthesia for Imaging of Children with Neuroblastoma.

Borgwardt L, Brok J, Andersen K, Madsen J, Gillings N, Fosbol M J Nucl Med. 2024; 65(8):1286-1292.

PMID: 38960713 PMC: 11294065. DOI: 10.2967/jnumed.123.267256.

Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers.

Asmundo L, Rizzetto F, Blake M, Anderson M, Mojtahed A, Bradley W J Clin Med. 2024; 13(11).

PMID: 38892992 PMC: 11172657. DOI: 10.3390/jcm13113281.

References

ODorisio M, Chen F, ODorisio T, Wray D, Qualman S . Characterization of somatostatin receptors on human neuroblastoma tumors. Cell Growth Differ. 1994; 5(1):1-8. View

Jacobs A, LENOIR P, Delree M, Ramet J, Piepsz A . Unusual Tc-99m MDP and I-123 MIBG images in focal pyelonephritis. Clin Nucl Med. 1990; 15(11):821-4. DOI: 10.1097/00003072-199011000-00013. View

Wilson L, Draper G . Neuroblastoma, its natural history and prognosis: a study of 487 cases. Br Med J. 1974; 3(5926):301-7. PMC: 1611711. DOI: 10.1136/bmj.3.5926.301. View

Sharp S, Trout A, Weiss B, Gelfand M . MIBG in Neuroblastoma Diagnostic Imaging and Therapy. Radiographics. 2016; 36(1):258-78. DOI: 10.1148/rg.2016150099. View

Huang S, Bolch W, Lee C, Van Brocklin H, Pampaloni M, Hawkins R . Patient-specific dosimetry using pretherapy [¹²⁴I]m-iodobenzylguanidine ([¹²⁴I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma. Mol Imaging Biol. 2014; 17(2):284-94. PMC: 4336853. DOI: 10.1007/s11307-014-0783-7. View

Shulkin B, Shapiro B, Hutchinson R . Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma. J Nucl Med. 1992; 33(10):1735-40. View

Boubaker A, Bischof Delaloye A . MIBG scintigraphy for the diagnosis and follow-up of children with neuroblastoma. Q J Nucl Med Mol Imaging. 2008; 52(4):388-402. View

Gelfand M, OHara S, Curtwright L, MacLean J . Pre-medication to block [(18)F]FDG uptake in the brown adipose tissue of pediatric and adolescent patients. Pediatr Radiol. 2005; 35(10):984-90. DOI: 10.1007/s00247-005-1505-8. View

Shapiro B, Copp J, Sisson J, Eyre P, Wallis J, BEIERWALTES W . Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med. 1985; 26(6):576-85. View

10.

Stefanelli A, Treglia G, Bruno I, Rufini V, Giordano A . Pharmacological interference with 123I-metaiodobenzylguanidine: a limitation to developing cardiac innervation imaging in clinical practice?. Eur Rev Med Pharmacol Sci. 2013; 17(10):1326-33. View

11.

Piccardo A, Puntoni M, Lopci E, Conte M, Foppiani L, Sorrentino S . Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma. Eur J Nucl Med Mol Imaging. 2014; 41(6):1046-56. DOI: 10.1007/s00259-014-2691-0. View

12.

Shulkin B, Hutchinson R, Castle V, Yanik G, Shapiro B, Sisson J . Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. Radiology. 1996; 199(3):743-50. DOI: 10.1148/radiology.199.3.8637999. View

13.

Lopci E, Piccardo A, Nanni C, Altrinetti V, Garaventa A, Pession A . 18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR. Clin Nucl Med. 2012; 37(4):e73-8. DOI: 10.1097/RLU.0b013e3182485172. View

14.

Pandit-Taskar N, Zanzonico P, Staton K, Carrasquillo J, Reidy-Lagunes D, Lyashchenko S . Biodistribution and Dosimetry of F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies. J Nucl Med. 2017; 59(1):147-153. PMC: 5750519. DOI: 10.2967/jnumed.117.193169. View

15.

Melzer H, Coppenrath E, Schmid I, Albert M, von Schweinitz D, Tudball C . ¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma. Eur J Nucl Med Mol Imaging. 2011; 38(9):1648-58. DOI: 10.1007/s00259-011-1843-8. View

16.

Matthay K, Shulkin B, Ladenstein R, Michon J, Giammarile F, Lewington V . Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force. Br J Cancer. 2010; 102(9):1319-26. PMC: 2865749. DOI: 10.1038/sj.bjc.6605621. View

17.

Schindler T, Yu C, Rossleigh M, Pereira J, Cohn R . False-positive MIBG uptake in pneumonia in a patient with stage IV neuroblastoma. Clin Nucl Med. 2010; 35(9):743-5. DOI: 10.1097/RLU.0b013e3181ea3502. View

18.

Arch M, Frush D . Pediatric body MDCT: a 5-year follow-up survey of scanning parameters used by pediatric radiologists. AJR Am J Roentgenol. 2008; 191(2):611-7. DOI: 10.2214/AJR.07.2989. View

19.

Jacobson A, Travin M . Impact of medications on mIBG uptake, with specific attention to the heart: Comprehensive review of the literature. J Nucl Cardiol. 2015; 22(5):980-93. DOI: 10.1007/s12350-015-0170-z. View

20.

Olivier P, Colarinha P, Fettich J, Fischer S, Frokier J, Giammarile F . Guidelines for radioiodinated MIBG scintigraphy in children. Eur J Nucl Med Mol Imaging. 2003; 30(5):B45-50. DOI: 10.1007/s00259-003-1138-9. View